← Leaderboards
Regina I Jakacki
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$100,247
Attributed
$100,247
Total exposure
17
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$100,247 · 17
By mechanism
M01$100,247 · 17
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Glenna Winnie$0
- Geoffrey Kurland$0
- Jonathan D Finder$115,425
- David M Orenstein$1,638,279
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHuman SubjectClinical ResearchNeoplasm /Cancer ChemotherapyPediatric Neoplasm /CancerDrug Screening /EvaluationAntineoplasticsPatient Oriented ResearchDrug Adverse EffectCarboplatinBrain NeoplasmsDosageClinical Trial Phase IChild (0-11)Combination ChemotherapyNeoplasm /Cancer Radiation TherapyMagnetic Resonance ImagingGliomaCombination Cancer TherapyPharmacokineticsNeoplasm /Cancer Relapse /RecurrenceClinical Trial Phase IiGadoliniumGrowth Factor Receptors
Grant awards (24)
ADVL0211: A PHASE IG3139 COMBINED WITH CYTOXICSOLID TUMORS$29,229
M01 · FY2005 · RR
PBTC-005 V 20: PHASE I TRIAL OF TEMOZOLOMIDE AND O6-BENZYLGUANINE IN PEDIATRIC$11,160
M01 · FY2005 · RR
ADVL0214: PHASE I STUDY OF SINGLE AGENT OSI-774 FOLLOWED OSI-774 W TEMOZOLOMIDE$9,300
M01 · FY2005 · RR
PBTC-010 V11: A PHASE II STUDY OF OXALIPLATIN IN CHILDREN WITH MEDULLOBLASTOMA,$1,594
M01 · FY2005 · RR
ADVL0311 PHS 1 STDY OF PEMETREXED IN CHLDRN AND ADLSCNTS WTH RCRRNT SLD TMRS$1,063
M01 · FY2005 · RR
PBTC-003: PHASE I TRIAL OF ESCALATING ORAL DOSES OF SCH 66336 IN PEDIATRIC PTS$797
M01 · FY2005 · RR
ADVL0116: PHASE I TRIAL AND PHARMACOKINETIC STUDY OF R115777 IN PEDIATRIC PTS$532
M01 · FY2005 · RR
PBTC-007: A PHASE I/II TRIAL OF ZD18239 (IRESSA TM) AND RADIATION IN PEDIATRIC$532
M01 · FY2005 · RR
ADVL0211: A Phase I..G3139... Combined with Cytoxic...Solid Tumors$16,294
M01 · FY2004 · RR
PBTC-005 v 2.0: Phase I Trial of Temozolomide and O6-Benzylguanine in Pediatric$10,610
M01 · FY2004 · RR
A Phase IV, Open-Label, Multicenter Study of the Safety and Antiemetic Effect of$6,063
M01 · FY2004 · RR
Phase I Study of Cereport (Labradimil) and Carboplatin with Radiation Therapy$4,547
M01 · FY2004 · RR
Phase I Study of Carboplatin and Irinotecan in Pts 1-21 Yrs with Tumors$3,600
M01 · FY2004 · RR
Phase II Trial of Cyclosporine, Etoposide Phosphate, Carboplatin &Vincristine$2,274
M01 · FY2004 · RR
ADVL0016: A Phase I Study of ZD1839 Iressa TM, an Oral Epidermal$758
M01 · FY2004 · RR
PBTC-012 v1.0: Phase I Study of Cilengitide (EMD 121974) in Children with Refra$758
M01 · FY2004 · RR
PBTC-010 v1.1: A Phase II Study of Oxaliplatin in Children with Medulloblastoma,$568
M01 · FY2004 · RR
PBTC-006: A Phase I/II Trial of ST1571 in Children with Newly Diagnosed Poor$568
M01 · FY2004 · RR
CCG09712--Phase I study of gadolinium texaphyrin &radiation in pontine glioma$0
M01 · FY2002 · RR
CCG09716--Phase II trial of cereport &carboplatin in childhood brain tumors$0
M01 · FY2002 · RR
CCG09712--Phase I study of gadolinium texaphyrin &radiation in pontine glioma$0
M01 · FY2001 · RR
CCG09716--Phase II trial of cereport &carboplatin in childhood brain tumors$0
M01 · FY2001 · RR
CCG09716--Phase II trial of cereport &carboplatin in childhood brain tumors$0
M01 · FY2000 · RR
CCG09712--Phase I study of gadolinium texaphyrin &radiation in pontine glioma$0
M01 · FY2000 · RR